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Localized Malignant Myxoid Anaplastic Mesothelioma 
of the Pericardium
Guang Zhi Yanga, b, Jing Lia, Hua Ye Dinga
Abstract
          Primary malignant mesothelioma of the pericardium is a rare 
cardiac neoplasm. Most are diffuse and have poor prognosis with 
median survival of six months. In the paper, we describe a young 
male patient having no exposure history of asbestos with localized 
malignant myxoid mesothelioma of the pericardium. The tumor 
displayed significant myxoid change in stroma, and anaplastic cy-
tology,  including  pleomorphy,  poor  cohesion,  prominent  nuclei, 
with high mitoses, which led to difficulty in diagnosis. The tumor 
showed typical immunohistochemical phenotypes of mesothelio-
ma, positive for WT-1, calretinin and CK5/6. Ki-67 labeling index 
was about 50% in general and nearly 80% in the most active areas. 
The patient showed better outcome. The report suggests the diag-
nosis of myxoid mesothelioma is supposed to rely on clinical data, 
and immunohistochemistry is assumed to be for differentiation.
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Introduction
 Primary malignant mesothelioma of the pericardium 
is a rare cardiac neoplasm, accounting for approximately 
0.0017% of cardiac and pericardial tumors [1]. As far as 
mesothelioma is concerned, pericardial mesothelioma repre-
sents no more than 1% of all [2]. In macroscopy, most fill the 
pericardial cavity or spread diffusely over the surface. Histo-
logically, mesothelioma is classified into four main subtypes, 
which are epithelioid, sarcomatoid, desmoplastic and bipha-
sic. However, it is recognized of a striking variation in the 
morphology. For example, myxoid change is an infrequent 
phenomenon taking place in epithelioid mesothelioma. Fur-
thermore, it may be so obvious that cases of which at least 
50% area containing a pronounced myxoid stroma that oc-
cupied more than 50% of the tumor volume are designated 
as myxoid mesothelioma [3]. Since myxoid mesothelioma, 
as one sort of seldom seen mesothelioma, was first described 
by Butchart in 1976[4], several reports in small series have 
presented, but none of the pericardium was seen. In most 
reported cases, the tumor cells were remarkably bland. In the 
paper, we reported one case of myxoid mesothelioma of the 
pericardium, forming a bulky neoplasm in the mediastinum 
with anaplastic cytologic characteristics.
Case Report
  A 23-year-old male presented with growing dyspnea 
in recent six months, who denied history of smoking and 
exposure to asbestos. CT scans demonstrated a pleural ef-
fusion and a well demarcated tumor in mediastinum. At sur-
gery the neoplasm was found to occupy most of the anterior 
mediastinum and grew on a slim pedicel connected with the 
pericardium. 
   Gross investigation revealed an ovoid mass measured 
9 cm × 5 cm × 4 cm with a smooth intact capsule and myxoid 
external appearance. The cut surface was obviously myxoid 
change with haemorrhage and necrosis. 
  The tumor was composed of abundant myxoid stroma 
comparted with fibrous tissues and veins, which was easily 
recognized even in low power scanning. The tumor cells, 
floated  in  such  mucin  pools,  admixed  with  inflammatory 
cells (Fig. 1A). Great variances were present in cell density 
and size (Fig.1B). The compact areas were composed mainly 
of tumor cells of medium size. Alternately, the larger cells 
were inclined to assemble in the loose areas, where giant 
odd cells were also occasional (Fig. 1C). The cells lacked 
cohesion, nearly individually dispersed, which were more 
significant in large cells. The tumor cells were epithelioid 
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with eosinophilic and irregular polygonal cytoplasms. The 
amounts and figures of cytoplasm were diverse, from a few 
to much, some even like the red streamer. The nuclei were 
coarse and prominent, whereas nucleoli were not common. 
Mitosis figures were quite frequent and estimated of more 
than 10 per 10 high power fields (Fig. 1D). 
 Immunohistochemical study displayed that the tumor 
cells were strongly positive for WT-1 (Fig. 1E), moderately 
positive for calretinin and CK5/6, weakly positive for AE1/
AE3, and locally positive for vimentin. Other immunostain-
ing items, including EMA, CEA, CgA, Syn, actin(pan), Des-
min, SMA, myoD1, CD34, CD31, HMB45, Melan A, S-100, 
CD30, bcl-2 and CD99, were all negative. The background 
cells were positive for LCA and CD68, which were regarded 
as lymphocytes and monocytes. The tumor cells were also 
diffusely positive for P53. The labeling index of Ki-67 stain-
Figure 1. (A) The tumor was composed of abundant myxoid stroma comparted with fibrous tissues and veins, in which the tumor cells float-
ed. Most of the tumor cells were medium, whereas some were large. The cells were lack of cohesion (×100, HE). (B) The tumor cells had 
ample amount of   eosinophilic cytoplasms with coarse and prominent nuclei. The cytoplasms were irregular, some like the red streamer 
(×400, HE). (C) The giant odd cells were present (×400, HE). (D) Mitosis figures were common, and three were marked in the high power 
field (×400, HE). (E) WT-1 was positive. (F) Ki-67 labeling index was high.
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ing was about 50% in general and nearly 80% in the most 
active areas (Fig. 1F).
Discussion
  
  Primary malignant mesothelioma of the pericardium 
is a rare cardiac lesion, which is diagnosed when such is 
excluded outside the pericardium. The pericardial mesothe-
lioma occurs in a wide range of ages with mean of 45, just 
like in other sites [1]. It is believed that a large proportion 
is induced by asbestos. Most displays pericardial thicken-
ing or diffusely spreading over the pericardium. Our patient 
was young without exposure history of asbestos, and showed 
a localized lump in the mediastinum without thickening of 
the pericardium or pleura. Clinically, the patient mainly dis-
played dyspnea, just like the general. However, the underly-
ing reason was assumed of extrusion to the lungs from the 
tumor rather than effusions, even the patient also had a little. 
  The main challenge of the report was what to diag-
nose, which verified that mesothelioma has so many variants 
in histological morphology leading to difficulty in diagno-
sis sometimes. The case was effluent in myxoid stroma and 
anaplastic tumor cells, which brought up with no explicit 
consideration clue. In our diagnosis experience, nearly all 
soft tissue tumors which could happen in mediastinum were 
excluded by immunohistochemistry, such as solitary fibrous 
tumor, rhabdomyosarcoma, synovial sarcoma, leiomyoma-
tous tumors, neurogenic tumors, and melanoma, lymphoma, 
even anaplastic carcinoma. The case displayed a localized 
mass, which was seldom present in mesotheliomas, but the 
important information that the tumor had a stalk connected 
with the paracardiac offered by the surgeons, sparked pos-
sibility of mesotheliomas. And the immunostaining results 
displayed that WT-1, calretinin and CK5/6 were positive, 
then diagnosis of mesothelioma was confirmed [5].
  Until  now,  descriptions  about  myxoid  mesothelioma 
were in small series [6, 7]. In a large review, Shia et al dem-
onstrated mxoid mesotheliomas represented 8% of their se-
ries of 234 cases [3]. They also identified that myxoid stroma 
was mainly composed of hyaluronidase-sensitive material. 
To recall normal mesothelial cells have the function of se-
creting glycosaminoglycans, particularly hyaluronic acid, it 
is easily understood that myxoid mesothelioma retained the 
function of the normal counterparts. 
   To the note, there are another group of mesotheliomas, 
which called mucin-positive mesothelioma [8]. The mucin 
was  also  hyaluronic  acid  type,  however,  it  was  confined 
to the cells, rather than extracellular myxoid stroma. Such 
group also displayed aberrant immunostaining for markers of 
adenocarcinoma such as CEA, which was not seen in myx-
oid mesotheliomas. It is supposed that the two mucin-rich 
mesotheliomas were not the same group of mesotheliomas. 
  Overall, the prognosis of the pericardial mesothelioma 
remains very poor with median survival of about six months 
after diagnosis and treatments such as surgery, radiotherapy 
and chemotherapy have modest efficacy. The literature has 
all prompted that myxoid mesothelioma patients have a bet-
ter prognosis than patients with other subtypes, which was 
reinforced by the morphology and immunohistochimestry. 
The tumor cells of myxoid mesothelia were always epithe-
lioid without significant atypia, and mitoses were not com-
man. Ki-67 index was testified to suggest survival in patients 
with mesotheliomas [9]. In the past reported cases, the Ki-67 
index was either minimal (less than 5%) or moderate (less 
than 30%), which displayed a low proliferation rate in gen-
eral. Contrarily, our case was quite different. The tumor cells 
are anaplastic, and mitoses were also common, estimated 
more than 10 per 10 high power fields. The Ki-67 labeling 
index was high, and nearly 80% in the most active areas. It 
was also thought to reach the diagnosis standard of pleomor-
phic mesothelioma. All these implied the poor prognosis. To 
make it more complicated, the case was the localized type, 
which was figured of more favorable outcome than the dif-
fuse type.      
  The plus and minus factors admixed, which made it 
more difficult to judge the prognosis. The case still survived 
one year after surgery without further radiotherapy and che-
motherapy. 
  According to our experiences, the mesotheliomas are 
very heterogeneous in morphology. The clinical features, in-
cluding exact tumor positions and connections with circum-
ambient organs, are important adjunct to diagnosis. Immu-
nohistochemistry is an essential mean to confirm diagnosis 
of mesothelioma. In summary, myxoid mesothelioma is one 
type of mesothelioma recapitulating the secretory function 
of the normal mesothelium. Further studies are needed to re-
solve the paradoxical problem about the survival.
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